CCaTS-CBD Pilot Awards for Team Science

2020 request for applications

Through the Dean's Fund for Team Science, the Center for Clinical and Translational Science (CCaTS) and the Center for Biomedical Discovery (CBD) jointly request applications for pilot projects to enhance team science at Mayo Clinic.

The goal of this request for applications is to help develop clinical-basic science partnerships in projects that have the potential to impact clinical practice at Mayo Clinic.

For 2020, CCaTS and CBD are seeking applications focused on addressing pediatric diseases, conditions and populations, including the structural, biochemical and cell biological mechanisms of pediatric development and disease. CCaTS and CBD anticipate awarding up to six grants of $75,000 (direct costs) for one year.

Eligibility

All associate consultants, senior associate consultants and consulting staff from all Mayo sites who will be able to complete the work during the funding period are eligible to apply.

Other eligibility criteria include:

  • Each proposal must have at least two co-principal investigators: one basic scientist and one active clinician. The proposal work plan should reflect approximately equal involvement and contribution of each co-principal investigator. The contact principal investigator should be listed as the principal investigator in the application tool.
  • The proposal should describe the disease relevance of the study and the potential for translation and application to clinical practice.
  • Preliminary data is not required but can be included.
  • Multicampus Mayo Clinic participation is encouraged, but subcontracts with other institutions are not allowed.
  • Each proposal should address how these pilot funds will be leveraged to apply for more substantive intramural or extramural funding, with a continued emphasis on team science.
  • Recipients of CCaTS-supported grant awards should expect to be asked to serve as reviewers for other grant applications from the funding body.

Application deadlines

Letters of intent are due no later than Monday, June 24, 2019, at 8 a.m. Central time.

After review of letters of intent, Mayo Clinic will extend invitations for full applications. Full applications are due on Wednesday, Aug. 21, 2019, at 8 a.m. Central time.

Timeline

  • Letter of intent deadline: June 24, 2019, 8 a.m. Central time
  • Full application deadline: Aug. 21, 2019, 8 a.m. Central time
  • Award activation period: Jan. 1, 2020 to Dec. 31, 2020

Funding

  • Awards of up to $75,000 in direct costs (no indirect costs) for study-related expenses.
  • Anticipated start date is Jan. 1, 2020. End date is Dec. 31, 2020.
  • Funds must be spent within the one-year award period — no extensions are granted.
  • Allowable costs include items such as personnel, core facilities and supplies. Unallowable costs include capital equipment, computers, other general-purpose equipment and subawards to institutions outside Mayo Clinic.

Letter of intent requirements

Letters of intent are due no later than Monday, June 24, 2019, 8 a.m. Central time, and should be submitted through the START application tool (must be logged in to the Mayo Clinic network).

Full application requirements (upon invitation)

After reviewing letters of intent, Mayo Clinic will extend invitations for full applications.

Applications are due no later than Wednesday, Aug. 21, 2019, at 8 a.m. Central time.

Invited applicants submit complete application packets through the START application tool (must be logged in to the Mayo Clinic network).

In the attachments, applicants are required to include:

  • Bibliography.
  • National Institutes of Health (NIH)-formatted biosketches for faculty team members using the new biographical sketch format.
  • Applicants may attach up to two PDFs of relevant articles published by the team.
  • Brief budget justification.

Review criteria

  • Innovation and originality of the proposed study.
  • Feasibility.
  • Translation potential.
  • How well the members of the team complement each other.
  • Quality of the plan for project management.
  • Quality of the plan for making decisions on scientific direction within the team.
  • How well the team plans to engage anticipated stakeholders of the research. Stakeholders may include practitioners, patients, regulatory agencies, the public and others.

Reporting

A final report is required at the end of the funding period and for one to three years annually after the funding period to track publications and grants resulting from the award.

Publications

The NIH Public Access Policy requires that all publications resulting from NIH funding be uploaded to PubMed Central. CTSA awards, including intramurally funded awards, must follow this policy. Mayo Clinic's NIH Public Access Policy intranet site (must be logged in to the Mayo Clinic network) guides awardees through the process of uploading publications.

Please remember to cite Mayo Clinic CCaTS in your publication using this format:

This publication (or project) was made possible by Mayo Clinic CTSA grant number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.

Contact

For questions about the application process, contact:

For scientific questions, contact:

  • Mark A. McNiven, Ph.D.
  • Director, Center for Biomedical Discovery
  • Email: mmcniven@mayo.edu